BRTX Biorestorative Therapies
- 1.260
- -0.030-2.33%
- 1.260
- +0.000+0.02%
Biorestorative Therapies News
Biorestorative Therapies | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Biorestorative Therapies | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Biorestorative Therapies | S-1: General form for registration of securities under the Securities Act of 1933
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | DEF 14A: Definitive information statements
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Biorestorative Therapies | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Biorestorative Therapies | S-3: Registration statement for specified transactions by certain issuers
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Biorestorative Therapies | DEF 14A: Definitive proxy statements
Analysis
Price Target
No Data
